Bionano Genomics (BNGO) Change in Account Payables (2017 - 2025)
Bionano Genomics (BNGO) has disclosed Change in Account Payables for 9 consecutive years, with -$399000.0 as the latest value for Q4 2025.
- Quarterly Change in Account Payables rose 77.08% to -$399000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.4 million through Dec 2025, up 59.88% year-over-year, with the annual reading at -$1.4 million for FY2025, 59.88% up from the prior year.
- Change in Account Payables hit -$399000.0 in Q4 2025 for Bionano Genomics, down from -$254000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $4.1 million in Q3 2021 to a low of -$4.4 million in Q4 2023.
- Historically, Change in Account Payables has averaged $97150.0 across 5 years, with a median of -$286000.0 in 2025.
- Biggest five-year swings in Change in Account Payables: soared 669.11% in 2021 and later plummeted 719.35% in 2025.
- Year by year, Change in Account Payables stood at $1.8 million in 2021, then skyrocketed by 73.31% to $3.2 million in 2022, then crashed by 238.15% to -$4.4 million in 2023, then soared by 60.4% to -$1.7 million in 2024, then skyrocketed by 77.08% to -$399000.0 in 2025.
- Business Quant data shows Change in Account Payables for BNGO at -$399000.0 in Q4 2025, -$254000.0 in Q3 2025, and -$318000.0 in Q2 2025.